|Day Low/High||3.37 / 3.49|
|52 Wk Low/High||2.80 / 9.95|
A Treatment for Relapsed/Refractory Peripheral T-Cell Lymphoma
Esperion Therapeutics, Minerva Neurosciences and BioCryst Pharmaceuticals were among the biotech stock movers in premarket trading on Tuesday.
Spectrum Pharmaceuticals, BioCryst Pharmaceuticals and Curis were among the biotech stock movers in premarket trading on Thursday.
In recent trading, shares of BioCryst Pharmaceuticals, Inc. have crossed above the average analyst 12-month target price of $7.78, changing hands for $7.80/share.
BioCryst's Hereditary angioedema drug-trial results not compelling.
Current drugs approved to prevent and reduce the frequency of HAE swelling attacks require injections, so BioCryst's once-daily pill has the potential to be more convenient.
BioCryst Pharmaceuticals, Sangamo Therapeutics and Cempra were among the biotech stock movers in premarket trading on Monday.
Shares of BioCryst (BCRX) fell double digits despite topping analysts' 4Q expectations.
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in BioCryst Pharmaceuticals, Inc. , where a total of 16,282 contracts have traded so far, representing approximately 1.6 million underlying shares.
Progenics, Alexion and BioCryst were among the biotech stock movers in premarket trading on Thursday.
Synergy Pharmaceuticals, Arrowhead Pharmaceuticals and BioCryst Pharmaceuticals were among the biotech stock movers in premarket trading on Wednesday.
Investors considering a purchase of BioCryst Pharmaceuticals, Inc. stock, but tentative about paying the going market price of $5.90/share, might benefit from considering selling puts among the alternative strategies at their disposal.
The number of new 12-month highs has climbed to 240.
The euphoria has calmed down, and if stocks can consolidate, we will have some better entry points.
Investors eyeing a purchase of BioCryst Pharmaceuticals, Inc. shares, but cautious about paying the going market price of $4.61/share, might benefit from considering selling puts among the alternative strategies at their disposal.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.